Evolent Health (EVH) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Evolent Health (EVH) PT Lowered to $33 at Cowen; Reiterates Outperform
August 8, 2017 7:42 AM EDTCowen lowered its price target on Evolent Health (NYSE: EVH) to $33.00 (from $35.00) while maintaining a Outperform rating following 2Q release. Reported revenues of $107.3M exceeded guidance, and consensus estimates, despite soft transformation sales. Adjusted EPS of ($0.13) was in-line with Street's expectations.
EVH... More
